WO2001021162A3 - Treating allergic and inflammatory conditions using desloratadine - Google Patents

Treating allergic and inflammatory conditions using desloratadine

Info

Publication number
WO2001021162A3
WO2001021162A3 PCT/US2000/025609 US0025609W WO2001021162A3 WO 2001021162 A3 WO2001021162 A3 WO 2001021162A3 US 0025609 W US0025609 W US 0025609W WO 2001021162 A3 WO2001021162 A3 WO 2001021162A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
allergic
work
baseline
inflammatory
person
Prior art date
Application number
PCT/US2000/025609
Other languages
French (fr)
Other versions
WO2001021162A2 (en )
Inventor
Kim Allen Heithoff
Original Assignee
Schering Corp
Kim Allen Heithoff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine

Abstract

The use of desloratadine for the preparation of a medicament for substantially returning work-related performance and/or workplace productivity of a person suffering from an allergic and/or inflammatory condition of the skin airway passages, e.g., season allergic rhinitis, perennial allergic rhinitis, atopic dermatitis, urticaria or allergic asthma to the person's baseline work-related performance and baseline workplace productivity.
PCT/US2000/025609 1999-09-22 2000-09-19 Treating allergic and inflammatory conditions using desloratadine WO2001021162A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US40059999 true 1999-09-22 1999-09-22
US09/400,599 1999-09-22

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001524588A JP2003509459A (en) 1999-09-22 2000-09-19 Treatment of allergic and inflammatory conditions
CA 2383214 CA2383214A1 (en) 1999-09-22 2000-09-19 Treating allergic and inflammatory conditions
EP20000965127 EP1214071A2 (en) 1999-09-22 2000-09-19 Treating allergic and inflammatory conditions using desloratadine

Publications (2)

Publication Number Publication Date
WO2001021162A2 true WO2001021162A2 (en) 2001-03-29
WO2001021162A3 true true WO2001021162A3 (en) 2002-03-07

Family

ID=23584252

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/025609 WO2001021162A3 (en) 1999-09-22 2000-09-19 Treating allergic and inflammatory conditions using desloratadine

Country Status (4)

Country Link
EP (1) EP1214071A2 (en)
JP (1) JP2003509459A (en)
CA (1) CA2383214A1 (en)
WO (1) WO2001021162A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659716A (en) * 1984-02-15 1987-04-21 Schering Corporation Antihistaminic 8-(halo)-substituted 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridines
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
WO1998006394A1 (en) * 1996-08-16 1998-02-19 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
WO1998034614A1 (en) * 1997-02-07 1998-08-13 Sepracor, Inc. Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
WO1998048803A1 (en) * 1997-04-25 1998-11-05 Schering-Plough Kabushiki Kaisha Eyedrops
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659716A (en) * 1984-02-15 1987-04-21 Schering Corporation Antihistaminic 8-(halo)-substituted 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridines
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
WO1998006394A1 (en) * 1996-08-16 1998-02-19 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
WO1998034614A1 (en) * 1997-02-07 1998-08-13 Sepracor, Inc. Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
WO1998048803A1 (en) * 1997-04-25 1998-11-05 Schering-Plough Kabushiki Kaisha Eyedrops
EP0978281A1 (en) * 1997-04-25 2000-02-09 Schering-Plough Kabushiki Kaisha Eyedrops

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GENOVESE: "loratadine and desethoxycarbonyl loratadine...", CLINICAL AND EXPERIMENTAL ALLERGY, vol. 27, no. 5, 1997, pages 559 - 567, XP000998792 *
HANDLEY DEAN A ET AL: "Methods for treating dermatitis using descarboethoxyloratadine.", 25 April 2000, OFFICIAL GAZETTE OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, VOL. 1233, NR. 4, PAGE(S) NO PAGINATION, APR. 25, 2000, ISSN: 0098-1133, XP000997862 *
MOLET, S. ET AL: "Inhibitory activity of loratadine and descarboxyethoxyloratadine on histamine-induced activation of endothelial cells", CLIN. EXP. ALLERGY ( 1997 ), 27(10), 1167-1174, XP000997866 *

Also Published As

Publication number Publication date Type
CA2383214A1 (en) 2001-03-29 application
EP1214071A2 (en) 2002-06-19 application
JP2003509459A (en) 2003-03-11 application
WO2001021162A2 (en) 2001-03-29 application

Similar Documents

Publication Publication Date Title
WO2005074913A3 (en) Compositions and methods for treating contracture
WO2007027788A3 (en) Analyte sensor introducer and methods of use
WO2004019863A3 (en) Combination therapy for treatment of fibrotic disorders
US5933864A (en) Body suit
WO2002096318A3 (en) Method for treating glaucoma v
WO2003080801A3 (en) Adipose stromal stem cells for tissue and vascular modification
CA2532804A1 (en) Substituted 2-aminotetralin for the treatment of depression
WO2004014352A3 (en) Methods for treating carbonic anhydrase mediated disorders
WO2003024386A8 (en) Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
WO2003009838A1 (en) Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
WO2003009859A1 (en) Immunotherapy for humans
WO2005000217A3 (en) Combination therapy for the treatment of dyslipidemia
USD561939S1 (en) Elastic ornamental hair band
CN203001185U (en) Squatting-standing assisting device
WO2004089416A3 (en) Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent
WO2004054581A3 (en) Cyclohexyl compounds as ccr5 antagonists
WO1995028418A3 (en) Tachykinin antagonists
WO2004054974A3 (en) Piperidine derivatives as ccr5 antagonists
WO2003078431A8 (en) Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
WO2001028535A3 (en) Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate
Narang et al. Verruca vulgaris following treatment with tacrolimus ointment
WO2002064748A8 (en) Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2004004658A3 (en) Methods and compositions relating to isoleucine boroproline compounds
WO2005027993A3 (en) Vascular access preservation in hemodialysis patients
CN2796432Y (en) Gloves special for electrician

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CZ DE DK DM DZ EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA US UZ VN YU ZA

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2383214

Country of ref document: CA

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CZ DE DK DM DZ EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2001 524588

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 10088629

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/003023

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2000965127

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000965127

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000965127

Country of ref document: EP